Article Details
Retrieved on: 2021-09-29 06:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Synaffix signed a licensing agreement with Shanghai Miracogen (now fully owned by LEPU BIOPHARMA CO., LTD), a Chinese biotechnology company with a clinical- ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here